IDXX News and Press, IDEXX Laboratories Inc. From 08/15/22

IDEXX Laboratories enjoys a dominant market position in the veterinary care ecosystem. It is also establishing itself in adjacencies like livestock and water testing. The company's business has sticky, recurring revenues with strong defensibility during uncertain economic times. ...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Growth Fund declined 18.69% (Institutional Shares) during the quarter ended June 30, 2022. We think that the co...

I'd characterize the financial performance here for IDEXX Laboratories as "mixed." The top and bottom lines have grown nicely over time, though the capital structure has deteriorated. In spite of this, IDXX stock is even more expensive than when I last reviewed the name. IDEXX Lab...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due t...

Image source: The Motley Fool. Idexx Laboratories (NASDAQ: IDXX) Q2 2022 Earnings Call Aug 02, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Idexx Laboratories (IDXX) Q2 2022 Earnings Call Transcript

IDEXX Laboratories, Inc. (IDXX) Q2 2022 Earnings Conference Call August 02, 2022 08:30 AM ET Company Participants Brian McKeon - Executive Vice President, Chief Financial Officer & Treasurer Jay Mazelsky - President & Chief Executive Officer Conference ...

IDEXX Laboratories press release ( NASDAQ: IDXX ): Q2 Non-GAAP EPS of $1.58 misses by $0.05 . Revenue of $860.55M (+4.2% Y/Y) misses by $1.57M . FY2022 Outlook : Revenue in the range of $3.305B to $3.385B vs. consensus of $3.41B;  operating margin...

IDEXX Laboratories ( NASDAQ: IDXX ) is scheduled to announce Q2 earnings results on Tuesday, August 2nd, before market open. The consensus EPS Estimate is $1.64 (-27.8% Y/Y) and the consensus Revenue Estimate is $863.58M (+4.5% Y/Y). Over the last 1 year, IDXX has be...

The middle of June marked a turning point for the stock market and new leadership has emerged for the recent run-up, according to Credit Suisse. Driving returns have been stocks that are Speculative (high correlation to Bitcoin ( BTC-USD )), Expensive (high P/E), Beaten Down (52...

A few days after Goldman Sachs upgraded IDEXX Laboratories ( NASDAQ: IDXX ), Stifel issued an opposite view on the animal health company this week, lowering its recommendation to Hold from Buy on weak vet visit data that analysts said paint an overly bullish 2022/23 forecast. ...